KMO and liver cancer: Experimental studies have demonstrated that reduced KMO expression promotes proliferation, invasion, and metastasis while inhibiting apoptosis in liver cancer cells, partly through its involvement in the epithelial-mesenchymal transition (EMT) process (28).